Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents-Reference-Cited by-同舟云学术

Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents

Published:2019-12-09 Issue:4 Volume:161 Page:842-855
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:PAIN

Author:

Tiwari Vinod,He Shao-Qiu,Huang Qian,Liang Lingli,Yang Fei,Chen Zhiyong,Tiwari Vineeta,Fujita Wakako,Devi Lakshmi A.,Dong Xinzhong,Guan Yun,Raja Srinivasa N.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology

Reference60 articles.

1. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice;Abdelhamid;J Pharmacol Exp Ther,1991

2. Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception;Akgun;Proc Natl Acad Sci U S A,2013

3. delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin;Arvidsson;J Neurosci,1995

4. Hot topics in opioid pharmacology: mixed and biased opioids;Azzam;Br J Anaesth,2019

5. Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes;Belcheva;J Biol Chem,2005

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrathecal administration of MCRT produced potent antinociception in chronic inflammatory pain models via μ-δ heterodimer with limited side effects;Biomedicine & Pharmacotherapy;2024-10

2. Exploring viral neuropathic pain: Molecular mechanisms and therapeutic implications;PLOS Pathogens;2024-08-08

3. Mahuang Fuzi Xixin decoction: A potent analgesic for neuropathic pain targeting the NMDAR2B/CaMKIIα/ERK/CREB pathway;Heliyon;2024-08

4. Ginkgolide B effectively mitigates neuropathic pain by suppressing the activation of the NLRP3 inflammasome through the induction of mitophagy in rats;Biomedicine & Pharmacotherapy;2024-08

5. Structure–Activity Relationship Study of CYM51010, an Agonist for the µ–δ Opioid Receptor Heterodimer;Chemical and Pharmaceutical Bulletin;2024-07-30